Is therapeutic anticoagulation improving renal outcomes in COVID-19?
J Community Hosp Intern Med Perspect
; 10(4): 306-309, 2020 Aug 02.
Article
in English
| MEDLINE | ID: covidwho-725436
ABSTRACT
We present three patients with COVID-19 who developed acute renal failure during hospitalization and were seen to have an improvement in their kidney function after being started on therapeutic anticoagulation with heparin (Target PTT 58-93 seconds) for varying indications (atrial fibrillation, popliteal vein thrombosis and a pulmonary embolism). Their kidney functions improved significantly following anticoagulation with a clear temporal relationship between the former and latter. Anticoagulation was held for one patient due to concern of gastrointestinal bleeding and his kidney functions worsened a day after stopping anticoagulation. D-dimer levels also improved with anticoagulation but the trend of other inflammatory markers remained unpredictable.
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Language:
English
Journal:
J Community Hosp Intern Med Perspect
Year:
2020
Document Type:
Article
Affiliation country:
20009666.2020.1785995
Similar
MEDLINE
...
LILACS
LIS